Member Info for elrico

for balance best to hold out both arms like wings ;)

I'd rather not take advice from a bank robber and a serial liar.

I'd rather not take advice from a bank robber and a serial liar.

Agreed Questa. Honest alternative views are fine because they encourage genuine debate and they do sometimes lead to a better understanding of the subject matter. Sadly, the likes of Korgi, Wolfstreet and Michaelmouse are not really interested in genuine debating. Pull them up on factual info and or ask them a question and they always hide and ignore. Michaelmouse demonstrated a classic misinformation campaign about funding, cash burn and discounted placing, etc. As soon as I offered up the facts and challenged him to counter, he reverts true to form, just as Korgi and 4khandle have done today. A simple question tripped them both up, even though I already gave them part of the answer. Just goes to show how little they actually know about a company they seek to trash, even more troubling when you realise the good this company could be for the health of many nations with health issues. Morally bankrupt some people are.

I am coming round to thinking Korgi is actually very astute fellow. He could be playing the court jester so LTI will share their research and views to save him all the time needed. Nah, surely not. ;) Good job my wife don't use this site or I'd be for the high jump.

Still no answer from Korgi about the revenues streams per product. Shock horror, though I don't think anyone is surprised at all by this. What TW expects and what reality proves are usually different when it comes to OPTI. What is more important, is what SOH expects, in this respect he fully expect PLC costs to be covered in 2018 and thus profitable in H1 2019. However, I previously stated SOH is being ultra cautious, thus in all probability will post a c �200/500k PROFIT by this time next year. In short, SOH will be 6 months ahead of schedule, IMHO. But hey, don't you worry my investment. I'm nudging 400% up :)

15p is my entry.....think I'll hold tight if that is alright with you. Now, do you have an answer to my question about revenues streams per product. Can you not put both braincells together to come up with a joint guess at least? Would you like me to help you.....again?!

Roger - the second part of your logic is flawed - for this to work the hired de-ramper would need to be suitably articulate and well versed in arguing their case, this is clearly not the case.. The other reason could be short, but I doubt this to be the case either. Attention seeking is more like it. It is a fact there a lot of lonely souls out there and both appear to lack social skills to help them.

OK - Neither of you know, not even brave enough to guess. Sums you up ;)

Babysitter otherwise engaged. :)

Just demonstrates how little research you have done. I have been hiding in plain sight.....:)

Korgi and 4kandle; how many revenues streams per products will company x generate for OPTI coffers? Forget the "single ingredient" theory, because it is the WRONG way to measure revenues streams.

The science....read and digest instead of making my case even easier. Better still, find an investment fund for your money, it's clearly the safer option for you.

There are numbers, you chose to ignore them because they are not in and RNS. Both TW and I have published numbers which have been direct quotes from SOH. My version https://goo.gl/kdka8s Note: the numbers are not made up my me. You either believe or you don't.

The problem from the LTH perspective is highlighted in you handle....your mistaking fork handles for 4 candles.If your argument is flawed, how can anyone take your version of events seriously. Korgi as an example, is illiterate in his understanding and thinks if he posts the same trite nonsense often enough people will believe him. In fact, the reverse is true because he unwittingly opens up the door for more reasoned and sound understanding of the science, business model, understanding of the strategy and multiple revenues streams. Korgi highlighted yet another flaw in his argument....he simply not understand OPTI have not signed a contracts for just a "single ingredient" as he calls it, it is for MULTIPLE products across MULTIPLE REVENUE STREAMS with probably MULTIPLE PARTNERS with Knightons company portfolio. Neither of you seem to understand this. If I was to ask either of you what a single contract mean for OPTI if company X used, say LP-LDL in 3 products in terms of revenue stream...I bet both of you would get it wrong. Prove me wrong!

If you believe a reasoned argument such as "How can a single ingredient company be worth almost a 22-30% of a company it supplies? opti at almost �60million (nearer �100mill if tw fantasy valuation is used), PFD at �300?" IS valid, then you are in serious danger of wealth destruction. What Korgi fails to understand about OPTI's business model, the groundswell of additional revenue streams building up over the next few months and all go to the bottom line at NO ADDITIONAL COST will transform OPTI soon enough for the patient. Korgi has chosen to single out a single contract, which by the way is for multiple products. Knighton simply have a 50/50 profit share, OPTI have at least 2 additional revenues stream. Korgi and you both fail to understand this. I suggest you both find another playground.

Nadda dues, zip, zilch, in fact we won't get any clue about revenues for.....oh 12 months or so. Go short you'll make a packet son. Let us know how you get on ;)

IMHO Per�s interview was brilliant and gave a great insight to his thinking in terms of why he joined OPTI � that spoke volumes to what he thought about OPTI�s science and products. Ref Cardiocare � again, this is nugget of info. There are multiple layers being peeled back and as each layer is peeled back it exposes more of the strategy to commercialisation. The typical process is OPTI develop the finished product with multiple partners - Galenicum being the latest (and quick off the mark) sell it as part of their STOP & GO range under the brand CardioCare. i.e they own the brand but license the product from OPTI. That allows OPTI to have a product produced for one company in one territory sold to multiple partners in other territories - and also in online store. This keeps manufacturing costs low as the volumes are high and gives commercial strategy the uplift across multiple partners. For example, GoFigure online store will be �shop window� as outlined in the interims (but not picked upon or discussed as yet) will look to integrate future products into this (Cardiobiome, CholBiome, SlimBiome, OptiBiome, ImmunoBiome etc) to build an online Health and WellBeing Consumer store. This shares the overhead, increases online traffic, allows for multiple purchases etc�Simply brilliant.

Revenues from SACCO, Nutrillnea and Galenicum x each product =

https://www.cphi.com/europe/exhibitors/G But there is nothing to suggest I am right about the launch. I have just been told that they did launch Cardiocare LP-LDL at the venue yesterday.